She had previously undergone a left modified radical mastectomy followed by 8 courses of CMF chemotherapy and tamoxifen treatment for 3 years, for an estrogen receptor (ER) (+++)-positive, progesterone receptor (PR) (+++)-positive, T1N0M0 invasive ductal breast carcinoma. The gene discussed is PGR; the disease is invasive ductal breast carcinoma.